2.5.2024
6
May
2024
7
8
Find more news and events
Suomeksi
In English
Bisphosphonates are commonly used to treat, for example, ostoporosis. One approach to mitigate their side effects is to utilize controlled delivery and release systems.
The results of the PhD study improve the understanding of molecular mechanisms underlying inflammasome activation in age-related macular degeneration and UV radiation-induced corneal inflammation.
Professor Jarkko Rautio was granted funding for an Academy Project called “Boosting delivery of LAT1-targeted boron carriers for improved boron neutron capture therapy”.
Finland has a strong public health care system; nevertheless, personal wealth is associated with the costs of hospital care and medication in people with Alzheimer’s disease.
The Finnish Research Impact Foundation’s new funding scheme gives professors the opportunity to spend one year working on their research with an industry partner, in an industry environment.
Researchers at the School of Pharmacy developed a new method for the accurate determination of the water content of water-soluble compounds. This plays a significant role in, e.g., drug dosage.
The U.S. Food and Drug Administration, FDA, has granted research funding to too ocular drug projects.
For the first time ever, researchers used the transporter protein OATP1C1, which is found in the brain, to enhance drug delivery into the brain, and especially into glial cells.
UEF and partners received over 3.2 million euros in development funding from various instruments.
A recent visit to Ghana by a UEF delegation witnessed the signing of two memoranda of understanding on education and research collaboration.